DOI:
10.1055/s-00022861
Aktuelle Kardiologie
LinksClose Window
References
Furlow B.
COVACTA trial raises questions about tocilizumabʼs benefit in COVID-19.
Lancet Rheumatol 2020;
2: e592
doi:10.1016/S2665-9913(20)30313-1
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.